R G Vink1, N J Roumans1, M Čajlaković2, J P M Cleutjens3, M V Boekschoten4, P Fazelzadeh4, M A A Vogel1, E E Blaak1, E C Mariman1, M A van Baak1, G H Goossens1. 1. Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands. 2. Joanneum Research Forschungsgesellschaft mbH, MATERIALS - Institute for Surface Technologies and Photonic, Sensorsystems, Weiz, Austria. 3. Department of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands. 4. Nutrition, Metabolism and Genomics Group, Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
Abstract
BACKGROUND/ OBJECTIVES: Although adipose tissue (AT) hypoxia is present in rodent models of obesity, evidence for this in humans is limited. Here, we investigated the effects of diet-induced weight loss (WL) on abdominal subcutaneous AT oxygen tension (pO2), AT blood flow (ATBF), AT capillary density, AT morphology and transcriptome, systemic inflammatory markers and insulin sensitivity in humans. SUBJECTS/ METHODS: Fifteen overweight and obese individuals underwent a dietary intervention (DI), consisting of a 5-week very-low-calorie diet (VLCD, 500 kcal day-1; WL), and a subsequent 4-week weight stable diet (WS). Body composition, AT pO2 (optochemical monitoring), ATBF (133Xe washout), and whole-body insulin sensitivity were determined, and AT biopsies were collected at baseline, end of WL (week 5) and end of WS (week 9). RESULTS: Body weight, body fat percentage and adipocyte size decreased significantly during the DI period. The DI markedly decreased AT pO2 and improved insulin sensitivity, but did not alter ATBF. Finally, the DI increased AT gene expression of pathways related to mitochondrial biogenesis and non-mitochondrial oxygen consumption. CONCLUSIONS: VLCD-induced WL markedly decreases abdominal subcutaneous AT pO2, which is paralleled by a reduction in adipocyte size, increased AT gene expression of mitochondrial biogenesis markers and non-mitochondrial oxygen consumption pathways, and improved whole-body insulin sensitivity in humans.
BACKGROUND/ OBJECTIVES: Although adipose tissue (AT) hypoxia is present in rodent models of obesity, evidence for this in humans is limited. Here, we investigated the effects of diet-induced weight loss (WL) on abdominal subcutaneous AT oxygen tension (pO2), AT blood flow (ATBF), AT capillary density, AT morphology and transcriptome, systemic inflammatory markers and insulin sensitivity in humans. SUBJECTS/ METHODS: Fifteen overweight and obese individuals underwent a dietary intervention (DI), consisting of a 5-week very-low-calorie diet (VLCD, 500 kcal day-1; WL), and a subsequent 4-week weight stable diet (WS). Body composition, AT pO2 (optochemical monitoring), ATBF (133Xe washout), and whole-body insulin sensitivity were determined, and AT biopsies were collected at baseline, end of WL (week 5) and end of WS (week 9). RESULTS: Body weight, body fat percentage and adipocyte size decreased significantly during the DI period. The DI markedly decreased AT pO2 and improved insulin sensitivity, but did not alter ATBF. Finally, the DI increased AT gene expression of pathways related to mitochondrial biogenesis and non-mitochondrial oxygen consumption. CONCLUSIONS: VLCD-induced WL markedly decreases abdominal subcutaneous AT pO2, which is paralleled by a reduction in adipocyte size, increased AT gene expression of mitochondrial biogenesis markers and non-mitochondrial oxygen consumption pathways, and improved whole-body insulin sensitivity in humans.
Authors: Lovisa E Johansson; Anders P H Danielsson; Hemang Parikh; Maria Klintenberg; Fredrik Norström; Leif Groop; Martin Ridderstråle Journal: Am J Clin Nutr Date: 2012-05-30 Impact factor: 7.045
Authors: Silvie Timmers; Ellen Konings; Lena Bilet; Riekelt H Houtkooper; Tineke van de Weijer; Gijs H Goossens; Joris Hoeks; Sophie van der Krieken; Dongryeol Ryu; Sander Kersten; Esther Moonen-Kornips; Matthijs K C Hesselink; Iris Kunz; Vera B Schrauwen-Hinderling; Ellen Blaak; Johan Auwerx; Patrick Schrauwen Journal: Cell Metab Date: 2011-11-02 Impact factor: 27.287
Authors: G Ganesan; R V Warren; A Leproux; M Compton; K Cutler; S Wittkopp; G Tran; T O'Sullivan; S Malik; P R Galassetti; B J Tromberg Journal: Int J Obes (Lond) Date: 2016-04-22 Impact factor: 5.095
Authors: Anthony E Civitarese; Stacy Carling; Leonie K Heilbronn; Mathew H Hulver; Barbara Ukropcova; Walter A Deutsch; Steven R Smith; Eric Ravussin Journal: PLoS Med Date: 2007-03 Impact factor: 11.069
Authors: R Jokinen; R Rinnankoski-Tuikka; S Kaye; L Saarinen; S Heinonen; M Myöhänen; E Rappou; S Jukarainen; A Rissanen; A Pessia; V Velagapudi; K A Virtanen; E Pirinen; K H Pietiläinen Journal: Int J Obes (Lond) Date: 2017-12-05 Impact factor: 5.095
Authors: Ioannis G Lempesis; Rens L J van Meijel; Konstantinos N Manolopoulos; Gijs H Goossens Journal: Acta Physiol (Oxf) Date: 2019-06-02 Impact factor: 6.311
Authors: Birgitta W van der Kolk; Maheswary Muniandy; Dorota Kaminska; Marcus Alvarez; Arthur Ko; Zong Miao; Armand Valsesia; Dominique Langin; Maija Vaittinen; Mirva Pääkkönen; Riikka Jokinen; Sanna Kaye; Sini Heinonen; Kirsi A Virtanen; Daniel P Andersson; Ville Männistö; Wim H Saris; Arne Astrup; Mikael Rydén; Ellen E Blaak; Päivi Pajukanta; Jussi Pihlajamäki; Kirsi H Pietiläinen Journal: J Clin Endocrinol Metab Date: 2021-04-23 Impact factor: 5.958
Authors: Rens L J Van Meijel; Ping Wang; Freek Bouwman; Ellen E Blaak; Edwin C M Mariman; Gijs H Goossens Journal: Front Physiol Date: 2022-01-04 Impact factor: 4.566